Panbela to present at access to giving virtual conference on july 15, 2021, at 10:30 a.m. et

Minneapolis, july 07, 2021 (globe newswire) --  panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that the company will present at access to giving virtual conference. the presentation will be given by panbela's president & chief executive officer, jennifer k. simpson, phd, msn, crnp.
PBLA Ratings Summary
PBLA Quant Ranking